Gilham’s healthcare industry career spans thirty years, including a stints as Chief Executive of Axis-Shield and various marketing, business development and R&D positions with GSK, Abbott Laboratories, Celltech and Amersham.
Ian Gilham appointed Chairman of the Board for Horizon Discovery
Gilham’s healthcare industry career spans thirty years, including a stints as Chief Executive of Axis-Shield and various marketing, business development and R&D positions with GSK, Abbott Laboratories, Celltech and Amersham.
Tags
Related posts
- New clinical trial aims to investigate skin patches to spot lung transplant rejection
- CureVac and MD Anderson Cancer Center partner to develop new cancer vaccines
- Researchers introduce new AI tool to help clinicians capture uncertainty in medical images
- New UK report highlights inequalities among people living with breast cancer
- ELRIG UK and SRG collaborate to advance life sciences professionals in drug discovery
